Specialities include:
- Providing scientific and strategic advice to company management including C-level / interim roles such as Chief Scientific Officer
- Evaluation or implementation of Research & Development (R&D) drug discovery platform and program strategies for the identification of next generation therapeutics
- Evaluation of novel targets, therapeutic areas and competitive landscape
- Development of investor- or partner-facing materials in support of venture capital investment, non-dilutive grant opportunities or asset- or collaboration-based deals
- Due diligence and the appraisal of in-licensing or out-licensing opportunities
- Design and management of bespoke drug-discovery solutions with CROs and other partners
- Preclinical pharmacology contributions to regulatory submissions and market access campaigns supporting the approval and launch of new medicines in the EU and USA
- Business development activities to support new business generation and forge new partnerships with companies in the Life Sciences sector
- Advisory Boards for the critique of R&D therapeutic area or program strategy
- Understanding, assessing and communicating scientific evidence for drug mechanism of action
- Scientific writing, presentation and multimedia projects, including access to proofreading and copy-editing expertise
